Loading stock data...

Biocon Limited

NSE: BIOCON BSE: BIOCON

NSE
371.30 4.50 (1.23%)

Prev Close

366.8

Open Price

365.5

Volume

4,875,319

Today Low / High

362.1 / 377.6

52 WK Low / High

291 / 424.95

Range

353 - 390

BSE
366.55 0.90 (0.29%)

Prev Close

366.55

Open Price

368.15

Volume

162,578

Today Low / High

362.5 / 377.3

52 WK Low / High

290.8 / 424.95

Range

348 - 385

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 371.3 (target range: 353 - 390), reflecting a change of 4.5 (1.22683%). On the BSE, it is listed at 366.55 (target range: 348 - 385), showing a change of 0.9 (0.2873%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

01 Feb 365.50 0.08%
30 Jan 364.00 0.77%
29 Jan 371.20 -1.59%
28 Jan 363.35 1.97%
27 Jan 367.65 -0.65%
23 Jan 372.55 -1.70%
22 Jan 365.00 2.19%
21 Jan 365.00 -0.04%
20 Jan 375.00 -2.17%
19 Jan 376.50 -0.12%
16 Jan 380.20 -0.67%
14 Jan 375.40 0.96%
13 Jan 377.00 0.08%
12 Jan 380.00 -2.16%
09 Jan 376.35 0.86%
08 Jan 387.05 -2.35%
07 Jan 387.05 0.00%
06 Jan 391.45 -1.61%
05 Jan 392.95 -0.41%

Biocon Limited Graph

Biocon Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Biocon Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 371.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 366.55 370.22 333.19 - 407.24
373.88 299.10 - 448.66
377.55 264.28 - 490.81
Bearish Scenario 366.55 362.88 326.60 - 399.17
359.22 287.38 - 431.06
355.55 248.89 - 462.22

Overview of Biocon Limited

ISIN

INE376G01013

Industry

Biotechnology

Vol.Avg

3,697,919

Market Cap

478,588,342,691

Last Dividend

0.5

Official Website

Visit Website

IPO Date

2004-04-07

DCF Diff

-10.13

DCF

377

Financial Ratios Every Investor Needs

Stock Dividend of BIOCON

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-07-04 July 04, 25 0.5 0.5 2025-07-04 2025-08-22
2024-07-05 July 05, 24 0.5 0.5 2024-07-05 2024-08-23
2023-07-07 July 07, 23 1.5 1.5 2023-07-07 2023-09-08
2022-06-30 June 30, 22 0.5 0.5 2022-07-01 2022-08-28
2019-07-18 July 18, 19 0.5 0.5 2019-07-19 2019-08-02 2019-04-25

Stock Rating Details for BIOCON

Metric Value Recommendation
Overall Rating B- Neutral
DCF Score 4 Buy
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 15,261.70 Cr 6,017.60 Cr 9,244.10 Cr 0.6057 1,026.40 Cr 3,166.90 Cr 4,719.90 Cr 1,013.30 Cr 8.46 3,123.90 Cr 0.0664
2024-03-31 14,755.70 Cr 5,582.20 Cr 9,173.50 Cr 0.6217 1,237.80 Cr 2,665.50 Cr 5,083.20 Cr 1,022.50 Cr 8.55 3,271.10 Cr 0.0693
2023-03-31 11,174.20 Cr 4,212.50 Cr 6,961.70 Cr 0.6230 1,298.30 Cr 2,184.90 Cr 3,330.30 Cr 462.70 Cr 3.88 2,656.70 Cr 0.0414
2022-03-31 8,184.00 Cr 3,172.90 Cr 5,011.10 Cr 0.6123 952.80 Cr 1,884.70 Cr 2,004.40 Cr 648.40 Cr 5.44 1,956.40 Cr 0.0792
2021-03-31 7,143.10 Cr 2,243.70 Cr 4,899.40 Cr 0.6859 553.10 Cr 0.00 Cr 2,597.80 Cr 740.50 Cr 6.24 1,652.20 Cr 0.1037

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3,227.10 Cr 58,797.30 Cr 31,084.80 Cr 21,644.0000 Cr 18,362.00 Cr 15,134.90 Cr 4,931.10 Cr 13,414.10 Cr 0.00 Cr 336.60 Cr 869.90 Cr 14,333.8000 Cr
2024-03-31 1,233.40 Cr 56,070.70 Cr 30,795.90 Cr 19,783.7000 Cr 16,276.70 Cr 15,043.30 Cr 4,943.90 Cr 12,208.20 Cr 634.10 Cr 310.70 Cr 1,096.40 Cr 15,358.8000 Cr
2023-03-31 1,323.50 Cr 52,042.80 Cr 29,554.00 Cr 17,866.9000 Cr 18,018.80 Cr 16,695.30 Cr 4,243.70 Cr 10,122.60 Cr 732.40 Cr 290.10 Cr 1,912.00 Cr 8,510.7000 Cr
2022-03-31 662.60 Cr 20,394.00 Cr 10,924.00 Cr 8,432.5000 Cr 5,146.60 Cr 4,484.00 Cr 2,298.20 Cr 9,415.50 Cr 549.80 Cr 1,215.10 Cr 517.00 Cr 3,828.0000 Cr
2021-03-31 952.60 Cr 18,522.30 Cr 10,014.70 Cr 7,626.9000 Cr 4,481.10 Cr 3,528.50 Cr 1,866.60 Cr 7,964.10 Cr 1,261.50 Cr 1,025.30 Cr -758.70 Cr 4,210.1000 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 4,061.2000 Cr -234.1000 Cr -1,854.0000 Cr 1,717.9000 Cr 2,004.3000 Cr 2,923.8000 Cr -2,136.6000 Cr 1,429.4000 Cr 572.9000 Cr -82.9000 Cr -0.3000 Cr
2024-03-31 2,953.9000 Cr -1,004.5000 Cr -2,332.7000 Cr 1,022.3000 Cr -380.4000 Cr 919.5000 Cr -1,680.5000 Cr 1,022.5000 Cr -1,271.2000 Cr -203.0000 Cr -886.4000 Cr
2023-03-31 1,852.5000 Cr -14,281.8000 Cr 13,048.7000 Cr 126.2000 Cr 641.1000 Cr 1,294.8000 Cr -1,726.3000 Cr 643.0000 Cr 12,415.9000 Cr -71.8000 Cr 886.2000 Cr
2022-03-31 1,176.6000 Cr -1,699.1000 Cr 242.1000 Cr -748.2000 Cr -243.3000 Cr 653.7000 Cr -1,924.8000 Cr 771.6000 Cr 321.3000 Cr 0.0000 Cr -414.0000 Cr
2021-03-31 1,159.7000 Cr -3,624.7000 Cr 2,564.0000 Cr -586.6000 Cr 72.3000 Cr 897.0000 Cr -1,746.3000 Cr 846.2000 Cr 1,888.8000 Cr 0.0000 Cr -445.4000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 4,262.50 Cr 1,547.00 Cr 2,715.50 Cr 0.6371 362.40 Cr 84.50 Cr 0.66 916.50 Cr 0.0198
2025-06-30 3,941.90 Cr 1,405.10 Cr 2,536.80 Cr 0.6435 1,669.10 Cr 31.40 Cr 0.26 689.10 Cr 0.0080
2025-03-31 4,417.00 Cr 2,293.00 Cr 2,124.00 Cr 0.4809 -177.50 Cr 344.50 Cr 2.88 1,100.90 Cr 0.0780
2024-12-31 3,821.40 Cr 1,359.30 Cr 2,462.10 Cr 0.6443 1,639.70 Cr 25.10 Cr 0.21 707.00 Cr 0.0066
2024-09-30 3,590.40 Cr 1,182.60 Cr 2,407.80 Cr 0.6706 1,573.80 Cr -16.00 Cr -0.13 678.15 Cr -0.0045

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 4,274.70 Cr 2,194.50 Cr 6,469.20 Cr 5,519.20 Cr 5,776.80 Cr 18,781.10 Cr 14,126.70 Cr 62,759.80 Cr 29,704.60 Cr
2025-06-30 2,905.00 Cr 3,184.00 Cr 6,089.00 Cr 5,845.00 Cr 5,756.00 Cr 18,969.00 Cr 13,629.00 Cr 61,395.00 Cr 29,397.00 Cr
2025-03-31 3,227.10 Cr 1,697.50 Cr 4,924.20 Cr 5,584.30 Cr 4,931.10 Cr 16,286.20 Cr 13,414.10 Cr 58,797.30 Cr 31,084.80 Cr
2024-12-31 2,569.00 Cr 549.00 Cr 3,118.00 Cr 6,365.00 Cr 5,052.00 Cr 15,651.00 Cr 0.00 Cr 58,013.00 Cr 30,448.00 Cr
2024-09-30 2,094.40 Cr 555.90 Cr 2,650.30 Cr 6,129.20 Cr 4,965.10 Cr 15,153.50 Cr 12,453.40 Cr 57,127.90 Cr 30,407.90 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 31.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 344.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 25.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -16.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 659.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2019-06-12 June 12, 19 2:1
2017-06-15 June 15, 17 3:1
2008-09-11 September 11, 08 2:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹371.30 ₹478,652,799,034.00 ₹4,875,319.00
Anthem Biosciences Ltd. ANTHEM ₹590.55 ₹331,658,815,618.00 ₹330,834.00
Piramal Pharma Limited PPLPHARMA ₹154.68 ₹204,698,467,266.00 ₹1,700,297.00
Syngene International Limited SYNGENE ₹473.45 ₹190,209,382,135.00 ₹835,327.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,194.50 ₹136,871,949,730.00 ₹62,980.00
Concord Biotech Limited CONCORDBIO ₹1,170.50 ₹122,453,266,782.00 ₹26,990.00
Jubilant Ingrevia Limited JUBLINGREA ₹622.50 ₹98,361,775,913.00 ₹48,622.00
Blue Jet Healthcare Limited BLUEJET ₹409.95 ₹71,112,150,979.00 ₹88,939.00
Supriya Lifescience Limited SUPRIYA ₹676.05 ₹54,410,396,940.00 ₹52,515.00
Zota Health Care Limited ZOTA ₹1,300.80 ₹39,456,717,624.00 ₹16,475.00
Dishman Carbogen Amcis Limited DCAL ₹215.86 ₹33,843,198,887.00 ₹54,000.00

Key Executives

Founder & Executive Chairperson
Kiran Mazumdar Shaw

Gender: female

Year Born: 1953

Chief Commercial Officer
Abhijit Zutshi

Gender: male

Year Born:

Chief Operating Officer
Arun Gupta

Gender: male

Year Born:

Interim Chief Financial Officer & Nodal Officer
Mukesh Kamath

Gender: male

Year Born:

Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business
Paul Vazhayil Thomas

Gender: male

Year Born: 1973

Company Secretary & Compliance Officer
Rajesh Shanoy

Gender: male

Year Born:

Head of Investor Relations
Saurabh Paliwal

Gender: male

Year Born:

MD, CEO & Director
Siddharth Mittal

Gender: male

Year Born: 1978

Head of Human Resources
Maninder Kapoor Puri

Gender: female

Year Born: 1973

SVP & Global Head Corporate Communications & Corporate Brand Biocon Group
Seema Shah Ahuja

Gender: female

Year Born: 1966

FAQs about Biocon Limited

Who is the CEO of the company?

The CEO is Siddharth Mittal.

What is the current market price of the stock?

The current price is ₹371.25.

What is the 52-week price range?

The range is ₹291-424.95.

What is the market capitalization of the company?

The market capitalization is ₹47,858.83 crores.

What is the dividend yield?

The dividend yield is 0.13%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 97.90.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Biocon Limited (ISIN: INE376G01013) is a leading Biotechnology in India. With a market capitalization of ₹47,858.83 crores and an average daily volume of 3,697,919 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.5.